Aperio Digital Pathology Ecosystem
Cancer Diagnostics
Key Facts
About Leica Biosystems
Leica Biosystems, founded in 1990 and headquartered in Buffalo Grove, USA, is a major player in the diagnostics and medical device sectors, specializing in comprehensive anatomic pathology workflows. The company leverages over 150 years of heritage (through its parent and legacy brands) to offer a fully integrated portfolio including histology instruments, immunohistochemistry (IHC) stainers, digital pathology scanners, and specimen tracking software. As a commercial-stage, revenue-generating entity, it serves laboratories and research institutions worldwide, aiming to standardize and digitize pathology to enhance diagnostic confidence and operational efficiency. It operates as a private company, a subsidiary of Danaher Corporation.
View full company profileTherapeutic Areas
Other Cancer Diagnostics Drugs
| Drug | Company | Phase |
|---|---|---|
| Isabl for Oncology | Isabi | Unknown |
| 3D AI Cancer Dx Platform (w/ PathNet) | Alpenglow Biosciences | Development |
| Oncology Assay Development | Transformative Biotech | Research |
| Cell Separation for Liquid Biopsy | SynderBio | Pre-clinical |
| TelomeScan (OBP-401, OBP-1101) | Oncolys BioPharma | Diagnostic |